A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy
Open accessThe DOI matches its Crossref record; 26 of the 29 references it cites were found in a registry or an index.
Abstract
In Brief Objective: To compare outcomes with early corticosteroid withdrawal (CSWD) and chronic low dose corticosteroid therapy (CCS). Summary Background Data: Final, 5-year results from the first randomized, double-blind, placebo-controlled trial of early CSWD (at 7 days posttransplant) are presented. Methods: Adult recipients of deceased and living donor kidney transplants without delayed graft function were randomized to receive prednisone (5 mg/d after 6 months posttransplant) or CSWD. Blinding was maintained for 5 years. This clinical trial is registered at www.clinicaltrials.gov (NCT00650468). Results: Results in 386 patients CSWD (n = 191), CCS (n = 195) are presented (CSWD; CCS). No differences were observed at 5 years in the proportion of patients experiencing: primary end point (composite of death, graft loss, or moderate/severe acute rejection) (30/191 (15.7%); 28/195 (14.4%)), patient death (11/191(5.8%);13/195 (6.7%)), death-censored graft loss (11/191 (5.8%); 7/195(3.6%)), biopsy confirmed acute rejection (BCAR) (34/191 (17.8%); 21/195 (10.8%), P = 0.058), moderate/severe acute rejection (15/191 (7.9%); 12/195 (6.2%)). Kaplan Meier analyses of the primary end point and its components also showed no differences; but BCAR was higher with CSWD (P = 0.04). Increased BCAR episodes were primarily corticosteroid-sensitive Banff 1A rejections: the incidence of antibody-treated BCAR was similar between groups (11/191 (5.8%); 13/195 (6.7%)). No differences in renal function were observed at 5 years: mean serum creatinine (1.5 ± 0.6; 1.5 ± 0.7 mg/dL), or Cockroft Gault calculated creatinine clearance (58.6 ± 19.7; 59.8 ± 20.5 mL/min). CSWD was associated with improved serum triglycerides (evaluated by mean and median change from baseline) at all time points (except at 5 years measured by mean change). Weight change also demonstrated changes favoring CSWD (median change from baseline at 5 years: 5.1 vs. 7.7 kg, P = 0.05). New onset diabetes after transplant (NODAT) was similar with respect to proportions who required treatment (23/107 (21.5%)); 18/86 (20.9%); however, fewer CSWD patients required insulin for NODAT at 5 years (4/107 (3.7%)); 10/86 (11.6%), P = 0.049). Changes in HgA1c values (from baseline) were lower in CSWD patients at all time points except 4 years. Conclusions: Early CSWD, compared with CCS, is associated with an increase in BCAR primarily because of mild, Banff 1A, steroid-sensitive rejection, yet provides similar long-term renal allograft survival and function. CSWD provides improvements in cardiovascular risk factors (triglycerides, NODAT requiring insulin, weight gain). Tacrolimus/MMF/antibody induction therapy allows early CSWD with results comparable to long-term low dose (5 mg/d) prednisone therapy. Final results from the first prospective, randomized, placebo-controlled, double-blind trial of early corticosteroid withdrawal in kidney transplantation are reported. This trial, which was blinded for 5 years, demonstrates that early corticosteroid withdrawal (under induction therapy with tacrolimus/mycophenolate mofetil therapy), as compared to chronic corticosteroid therapy, provides similar patient survival, and renal allograft survival and function. Early corticosteroid withdrawal was associated with increased acute rejection risk, but also provided improvements in several corticosteroid-related morbidities including post-transplant diabetes, weight gain, and triglycerides.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other more unique risk factors in this population include genetic polymorphisms, polycystic kidney disease, hepatitis C, and cytomegalovirus status.1579–1581”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1581]
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
The Banff 97 working classification of renal allograft pathology
Racusen, L. C., Solez, K., Colvin, R. B., Bonsib, S. M., Castro, M. C., Cavallo, T., Croker, B. P., Demetris, A. J., Drachenberg, C. B., Fogo, A. B., et al. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00299.x · Cited by 3,033
Immunosuppression: Evolution in Practice and Trends, 1994–2004
Meier-Kriesche, H.-U., Li, S., Gruessner, R. W. G., Fung, J. J., Bustami, R. T., Barr, M. L., & Leichtman, A. B. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01270.x · Cited by 559
&NA; (1999) · Transplantation · doi:10.1097/00007890-199912270-00009 · Cited by 277
Rostaing, L., Cantarovich, D., Mourad, G., Budde, K., Rigotti, P., Mariat, C., Margreiter, R., Capdevilla, L., Lang, P., Vialtel, P., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000154915.20524.0a · Cited by 249
Effects of Low-Dose Prednisone on Bone Metabolism
Ton, F. N., Gunawardene, S. C., Lee, H., & Neer, R. M. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041125 · Cited by 223
Vanrenterghem, Y., Lebranchu, Y., Hen??, R., Oppenheimer, F., & Ekberg, H. (2000) · Transplantation · doi:10.1097/00007890-200011150-00015 · Cited by 213
Sinclair, N. (1992) · Europe PMC (PubMed Central) · Cited by 203
Ratcliffe, P., Dudley, C., Higgins, R., Firth, J., Smith, B., & Morris, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02510-x · Cited by 178
Research works printed but not linked: 2
- Sinclair, 1992, Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts., Can Med Assoc J, 147, 645
- Woodle, 2005, A randomized, prospective, multicenter study of thymoglobulin in renal transplantation for induction and minimization of steroids (TRIMS)., Am J Transplant, 5, 571
Cited by
Items 201–300 of 472
Barbour, S. J., Djurdjev, O., Gill, J. S., Dong, J. J., & Gill, J. (2019) · Kidney International · doi:10.1016/j.kint.2019.02.041 · Cited by 16
pre-existing diabetes and PTDM in kidney transplant recipients: how to handle immunosuppression
Chevallier, E., Jouvé, T., Rostaing, L. P. E., Malvezzi, P., & Noble, J. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1851596 · Cited by 16
Gérard, A. O., Barbosa, S., Anglicheau, D., Couzi, L., Hazzan, M., Thaunat, O., Blancho, G., Caillard, S., Sicard, A., & French SOT COVID Registry (2022) · Transplantation · doi:10.1097/tp.0000000000004254 · Cited by 16
Prevention and management of transplant-associated diabetes
Jenssen, T. G., & Hartmann, A. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.628936 · Cited by 18
Aull, M. J., Dadhania, D. M., Afaneh, C. I., Leeser, D. B., Hartono, C., Lee, J. B., Serur, D. S., Pizzo, J. J. D., Suthanthiran, M., & Kapur, S. (2012) · Transplantation · doi:10.1097/tp.0b013e318265c461 · Cited by 16
Gabardi, S., Townsend, K. R., Martin, S. T., & Chandraker, A. K. (2013) · Transplant Infectious Disease · doi:10.1111/tid.12087 · Cited by 16
Mosli, M. H., Croome, K. P., Qumosani, K. M., Al-Judaibi, B., Marotta, P., & Chandok, N. (2012) · The American Journal of Gastroenterology · doi:10.14309/00000434-201210001-01645 · Cited by 18
van den Born, J. C., Meziyerh, S., Vart, P., Bakker, S. J. L., Berger, S. P., Florquin, S., de Fijter, J. W., Neto, A. W. G., Idu, M. M., Pol, R. A., et al. (2023) · Transplantation · doi:10.1097/tp.0000000000004776 · Cited by 17
Krämer, B. K., Klinger, M., Włodarczyk, Z., Ostrowski, M., Midvedt, K., Stefoni, S., Citterio, F., Pietruck, F., Squifflet, J., Segoloni, G., et al. (2009) · Clinical Transplantation · doi:10.1111/j.1399-0012.2009.01162.x · Cited by 15
Stevens, R. B., Foster, K. W., Miles, C. D., Lane, J. T., Kalil, A. C., Florescu, D. F., Sandoz, J. P., Rigley, T. H., Nielsen, K. J., Skorupa, J. Y., et al. (2014) · Transplantation · doi:10.1097/tp.0000000000000250 · Cited by 15
Numakura, K., Kagaya, H., Yamamoto, R., Komine, N., Saito, M., Hiroshi, T., Akihama, S., Inoue, T., Narita, S., Tsuchiya, N., et al. (2015) · Disease Markers · doi:10.1155/2015/179434 · Cited by 14
Willicombe, M. K., Kumar, N., Goodall, D., Clarke, C., McLean, A. G., Power, A. J., & Taube, D. H. (2014) · Clinical Transplantation · doi:10.1111/ctr.12476 · Cited by 14
Treatment-Resistant Hypertension in the Transplant Recipient
Lakkis, J. I., & Weir, M. R. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.08.010 · Cited by 14
Gaber, A. O., Moore, L. W., Alloway, R. R., Woodle, E. S., Pirsch, J. D., Shihab, F. S., Henning, A., Fitzsimmons, W. E., Holman, J., Reisfield, R., et al. (2013) · Transplantation · doi:10.1097/tp.0b013e3182777efb · Cited by 14
Self-citationLymphocyte-depleting induction and steroid minimization after kidney transplantation: A review
Naesens, M., Berger, S. P., Biancone, L., Crespo, M., Djamali, A., Hertig, A., Öllinger, R., Portolés, J. M., Zuckermann, A. O., & Pascual, J. (2016) · Nefrología · doi:10.1016/j.nefro.2016.03.019 · Cited by 14
Effect of glucocorticoid withdrawal on glucocorticoid inducing bone impairment
Shen, G., Ren, H., Qiu, T., Liang, D., Wei, Q., Tang, J., Zhang, Z., Yao, Z., Zhao, W., & Jiang, X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.07.036 · Cited by 14
Liu, A., Woodside, K. J., Augustine, J. J., & Sarabu, N. (2018) · Clinical Transplantation · doi:10.1111/ctr.13381 · Cited by 14
Bae, S., Chen, Y., Sandal, S., Lentine, K. L., Schnitzler, M. A., Segev, D. L., & McAdams‐DeMarco, M. (2024) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfae218 · Cited by 13
Moving Beyond Minimization Trials in Kidney Transplantation
Matas, A. J., & Gaston, R. S. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015030245 · Cited by 16
Emami, S., Huang, E., Kuo, H., Kamgar, M. K., & Bunnapradist, S. (2011) · Clinical Transplantation · doi:10.1111/j.1399-0012.2011.01517.x · Cited by 13
Is it safe to withdraw steroids within seven days of renal transplantation?
Zhang, X., Huang, H., Han, S., Fu, S., & Wang, L. (2012) · Clinical Transplantation · doi:10.1111/ctr.12015 · Cited by 13
Modern Immunosuppressive Therapy in Kidney Transplantation
Zhang, R. (2013) · Open Journal of Organ Transplant Surgery · doi:10.4236/ojots.2013.32005 · Cited by 13
Post-transplantation diabetes mellitus in pediatric patients
Grundman, J. B., Wolfsdorf, J. I., & Marks, B. E. (2020) · Hormone Research in Paediatrics · doi:10.1159/000514988 · Cited by 12
Role of steroid maintenance in sensitized kidney transplant recipients
Sureshkumar, K. K., Marcus, R. J., & Chopra, B. (2015) · World Journal of Transplantation · doi:10.5500/wjt.v5.i3.102 · Cited by 12
Engberg, H., Wehberg, S., Bistrup, C., Heaf, J. G., Sørensen, S. S., Thiesson, H. C., Hansen, J. M., Svensson, M. H. S., Green, A., & Marckmann, P. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw304 · Cited by 12
Corticosteroid minimization in renal transplantation: Careful patient selection enables feasibility
Vlachopanos, G., Bridson, J.-M., Sharma, A. K., & Halawa, A. M. (2016) · World Journal of Transplantation · doi:10.5500/wjt.v6.i4.759 · Cited by 12
Vock, D. M., & Matas, A. J. (2019) · Transplant International · doi:10.1111/tri.13530 · Cited by 13
Egbuna, O. I., Davis, R. B., Chudinski, R., Pavlakis, M., Rogers, C. C., Molakatalla, P., Johnson, S. R., Karp, S. J., Monaco, A. P., Tang, H. L., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e3181b27d44 · Cited by 12
Oxidative Stress Indices in Rats Under Immunosuppression
Kędzierska, K., Sporniak–Tutak, K., Bober, J., Safranow, K., Olszewska, M. J., Jakubowska, K., Domański, L., Gołembiewska, E., Kwiatkowska, E., Laszczyńska, M., et al. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.09.021 · Cited by 12
Bossini, N., Sandrini, S., Casari, S., Tardanico, R., Maffeis, R., Setti, G., Valerio, F., Forleo, M. A., Nodari, F., & Cancarini, G. C. (2014) · Transplant International · doi:10.1111/tri.12377 · Cited by 12
Wiseman, A. C. (2019) · Clinical Liver Disease · doi:10.1002/cld.814 · Cited by 12
Mejía, J. C., Basu, A., & Shapiro, R. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4096-3.00017-9 · Cited by 13
Song, T., Jiang, Y., Liu, J., Wang, Z., Zeng, J., Huang, Z., Fan, Y., Wang, X., & Lin, T. (2019) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12064 · Cited by 12
Impact of kidney transplantation on functional status
Ali, H., Soliman, K., Mohamed, M., Rahman, M., Herberth, J., Fülöp, T., & Elsayed, I. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1962963 · Cited by 11
Nishioka, S., Sofue, T., Inui, M., Nishijima, Y., Moriwaki, K., Hara, T., Mashiba, T., Kakehi, Y., & Kohno, M. (2014) · Transplantation Proceedings · doi:10.1016/j.transproceed.2013.11.153 · Cited by 13
Lin, S., Henning, A. K., Akhlaghi, F., Reisfield, R., Vergara-Silva, A. L., & First, M. R. (2014) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000125 · Cited by 11
Self-citationBamoulid, J., Crépin, T., Courivaud, C., Rebibou, J.-M., Saas, P., & Ducloux, D. (2017) · Transplantation Reviews · doi:10.1016/j.trre.2017.02.004 · Cited by 11
Early steroid withdrawal in HIV-infected kidney transplant recipients: Utilization and outcomes
Werbel, W. A., Bae, S., Yu, S., Ammary, F. A., Segev, D. L., & Durand, C. M. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16195 · Cited by 11
Bredewold, O. W., Chan, J., Svensson, M., Bruchfeld, A. N., de Fijter, J. W., Furuland, H., Grinyo, J. M., Hartmann, A., Holdaas, H., Hellberg, O., et al. (2022) · Kidney Medicine · doi:10.1016/j.xkme.2022.100574 · Cited by 11
Current Concepts of Immunosuppression and Side Effects
Khurana, A., & Brennan, D. C. (2009) · Springer eBooks · doi:10.1007/978-3-540-79343-4_2 · Cited by 11
Mihovilović, K., Maksimović, B., Kocman, B., Guštin, D., Vidas, Ž., Bulimbašić, S., Ljubanović, D. G., Matovinović, M. S., & Knotek, M. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005005 · Cited by 11
Hernández, D., Alonso-Titos, J., Vázquez, T., León, M., Caballero, A., Cobo, M. Á., Sola, E., López, V., Esteban, P. R., Cruzado, J. M., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10092005 · Cited by 11
Tahir, S., Gillott, H., Jackson‐Spence, F., Nath, J., Mytton, J., Evison, F., & Sharif, A. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014069 · Cited by 11
Cerise, A. C., Shaker, T. M., Nguyen, P. L., Dinesh, A., Jackson, S., Kandaswamy, R., & Riad, S. M. (2022) · Transplantation · doi:10.1097/tp.0000000000004295 · Cited by 10
Steroid Avoidance or Withdrawal After Kidney Transplantation: A Balancing Act
Sprangers, B., & Vanrenterghem, Y. F. C. (2010) · Transplantation · doi:10.1097/tp.0b013e3181e5927a · Cited by 10
Stanfill, A. G., Hathaway, D., Cashion, A. K., Homayouni, R., Cowan, P. A., Thompson, C. L., Madahian, B., & Conley, Y. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138885 · Cited by 10
Desai, V. C. A., Ferrand, Y., Cavanaugh, T. M., Kelton, C. M. L., Caro, J. J., Goebel, J., & Heaton, P. C. (2017) · Medical Decision Making · doi:10.1177/0272989x17700879 · Cited by 10
Novel management of diabetes in kidney transplantation
Ong, S., & Rhee, C. M. (2021) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000665 · Cited by 10
Aref, A., Sharma, A. K., & Halawa, A. M. (2021) · World Journal of Transplantation · doi:10.5500/wjt.v11.i4.99 · Cited by 10
Kidney Transplantation: A Guide to the Care of Kidney Transplant Recipients
McKay, D. B., & Steinberg, S. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1690-7 · Cited by 10
Greanya, E. D., Poulin, E., Partovi, N., Shapiro, R. J., Al-Khatib, M., & Ensom, M. H. H. (2012) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp110287 · Cited by 10
The Tradeoff Between the Risks of Acute Rejection and New-Onset Diabetes After Kidney Transplant
Klein, C. L., & Brennan, D. C. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.09.010 · Cited by 10
Individualized Diets in Patients with Kidney Disease and Kidney Transplants: A Narrative Review
Hu, L., Borelli, G., Gessaroli, E., Ruotolo, C., Bin, S., Papalia, G., Patella, G., Liberti, M. E., Baraldi, O., Zaza, G., et al. (2025) · Life · doi:10.3390/life15060896 · Cited by 10
Long-Term Outcomes Following Sirolimus Conversion after Renal Transplantation
Soliman, K., Mogadam, E., Laftavi, M. R., Patel, S. K., Feng, L., Said, M., & PANKEWYCZ, O. G. (2014) · Immunological Investigations · doi:10.3109/08820139.2014.947033 · Cited by 9
Taber, D. J., McGillicuddy, J. W., Bratton, C. F., Rohan, V., Nadig, S. N., DuBay, D. A., & Baliga, P. K. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000002366 · Cited by 11
Prednisone‐free maintenance immunosuppression in obese kidney transplant recipients
Matas, A. J., & Vock, D. M. (2019) · Clinical Transplantation · doi:10.1111/ctr.13668 · Cited by 10
Pathak, V., Madhavan, D., Narayanasamy, K., Kumar, S., Ramalingam, V., Sengodagounder, B., & Bodonyi-Kovacs, G. (2019) · Transplantation Direct · doi:10.1097/txd.0000000000000923 · Cited by 9
Stevens, R. B., Foster, K. W., Miles, C. D., Kalil, A. C., Florescu, D. F., Sandoz, J. P., Rigley, T. H., Malik, T., & Wrenshall, L. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139247 · Cited by 9
Overview of Immunosuppressive Therapies in Renal Transplantation
Gabardi, S., & Tichy, E. M. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0008-0_6 · Cited by 8
Diabetic Kidney Disease in Post-Kidney Transplant Patients
Pham, N.-Y. T., Cruz, D., Marin, L. M., Ravender, R., & García, P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030793 · Cited by 9
Bae, S., McAdams-DeMarco, M. A., Massie, A. B., Garonzik‐Wang, J., Coresh, J., & Segev, D. L. (2021) · Transplantation · doi:10.1097/tp.0000000000003777 · Cited by 8
Successful DCD Kidney Transplantation Using Early Corticosteroid Withdrawal
Chudzinski, R., Khwaja, K. O., Teune, P., Miller, J., Tang, H. L., Pavlakis, M., Rogers, C. C., Johnson, S. R., Karp, S. J., Hanto, D. W., et al. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02922.x · Cited by 8
Zachariah, M. S., Nader, N. D., Brar, J., Singh, N. K., Venuto, R. C., Patel, S. K., Said, M., Laftavi, M. R., & PANKEWYCZ, O. G. (2014) · Transplantation Proceedings · doi:10.1016/j.transproceed.2013.07.067 · Cited by 8
A Prospective Study of Depression and Weight Change After Kidney Transplant
Stanfill, A. G., Hathaway, D., Bloodworth, R. F., & Cashion, A. K. (2016) · Progress in Transplantation · doi:10.1177/1526924816632118 · Cited by 8
Alsheikh, R., & Gabardi, S. (2018) · Progress in Transplantation · doi:10.1177/1526924818800039 · Cited by 8
Fitzsimmons, W. E., & Naesens, M. (2023) · Transplantation · doi:10.1097/tp.0000000000004696 · Cited by 8
Heldal, K., & Midtvedt, K. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0082-z · Cited by 8
Takeuchi, H., Matsuno, N., Hirano, T., Gulimire, M., Hama, K., Nakamura, Y., Iwamoto, H., Toraishi, T., Kawaguchi, T., Okuyama, K., et al. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1578 · Cited by 8
Recurrent Immunoglobulin A Nephropathy after Kidney Transplant—An Updated Review
Han, H. S., Lubetzky, M., Anandasivam, N. S., Cox, R. A., & Lee, B. K. (2023) · Transplantology · doi:10.3390/transplantology4030016 · Cited by 11
Steroid free immunosuppression is associated with enhanced Th1 transcripts in kidney transplantation
Hrubá, P., Týcová, I., Krepsova, E., Girmanová, E., Sekerková, A., Slatinská, J., Stříž, I., Honsová, E., & Viklický, O. (2017) · Transplant Immunology · doi:10.1016/j.trim.2017.03.001 · Cited by 7
Impact of Corticosteroid-Free Regimen on Interstitial Fibrosis Following Kidney Transplantation
Ville, S., Renaudin, K., Rostaing, L. P. E., Péré, M., Kamar, N., Legendre, C. M., Morélon, E., Cassuto, É., Mariat, C., Dürrbach, A., et al. (2025) · Kidney International Reports · doi:10.1016/j.ekir.2025.04.004 · Cited by 7
Frezza, G., Colli, L. M., de Antônio, S. R., & de Castro, M. (2014) · Transplant Immunology · doi:10.1016/j.trim.2014.04.002 · Cited by 7
Immune Minimization Strategies in Renal Transplantation
Brar, J., & Nader, N. D. (2014) · Immunological Investigations · doi:10.3109/08820139.2014.937492 · Cited by 7
Nainani, N., Patel, N., Tahir, N., Kumar, R., Weber-Shrikant, E., Gundroo, A. A., Murray, B. M., Tornatore, K. M., Blessios, G. A., & Venuto, R. C. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr608 · Cited by 7
Chon, W. J., Desai, A., Wing, C., Arwindekar, D. J., Tang, I. Y. S., Josephson, M. A., & Akkina, S. K. (2016) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2016.73021 · Cited by 7
Induction Therapy: A Modern Review of Kidney Transplantation Agents
Afaneh, C. I. (2013) · Journal of Transplantation Technologies & Research · doi:10.4172/2161-0991.s4-001 · Cited by 9
Immunosuppression in solid organ–transplant recipients and impact on nutrition support
Wilson, N. K., & Kataria, A. D. (2023) · Nutrition in Clinical Practice · doi:10.1002/ncp.11099 · Cited by 7
Immunosuppressive Drugs in Organ Transplant Recipients – Rationale for Critical Selection
Stucker, F., Marti, H., & Hunger, R. E. (2012) · Current problems in dermatology · doi:10.1159/000335148 · Cited by 7
Precision Medicine and Personalized Approach to Renal Transplantation
Dafoe, D. C., Tantisattamo, E., & Reddy, U. G. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.05.005 · Cited by 7
Bae, S., Garonzik‐Wang, J., Massie, A. B., McAdams‐DeMarco, M., Coresh, J., & Segev, D. L. (2020) · Clinical Transplantation · doi:10.1111/ctr.14176 · Cited by 7
New Onset Diabetes Mellitus after Transplant: The Challenge Continues
Aziz, F. (2021) · Kidney360 · doi:10.34067/kid.0004042021 · Cited by 7
Feldkamp, T., & Linkermann, A. (2013) · Der Nephrologe · doi:10.1007/s11560-012-0713-0 · Cited by 6
Gosmanova, E. O., Tangpricha, V., & Gosmanov, A. R. (2012) · Endocrine Practice · doi:10.4158/ep12016.ra · Cited by 6
Immunosuppression in Kidney Transplant Recipients: An Update for the General Nephrologist
Jawdeh, B. G. A., & Me, H. M. (2024) · Advances in Kidney Disease and Health · doi:10.1053/j.akdh.2024.05.001 · Cited by 6
Corticosteroid and calcineurin inhibitor sparing regimens in kidney transplantation
Cortazar, F. B., Diaz-Wong, R., Roth, D. A., & Isakova, T. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft231 · Cited by 6
Djamali, A., Pietrangeli, C. E., Gordon, R. D., & Legendre, C. M. (2010) · Kidney International · doi:10.1038/ki.2010.211 · Cited by 7
Corticosteroid elimination in simultaneous liver–kidney transplantation recipients
Weber, N. K., Wiseman, A. C., & Trotter, J. F. (2009) · Clinical Transplantation · doi:10.1111/j.1399-0012.2009.01051.x · Cited by 6
Complications of Immunosuppression
McDermott, J. K. (2020) · Organ and tissue transplantation · doi:10.1007/978-3-319-58054-8_21 · Cited by 6
Rogers, C. C., Asipenko, N., Horwedel, T. A., Gautam, S., Goldfarb‐Rumyantzev, A. S., Pavlakis, M., Johnson, S. R., Karp, S. J., Evenson, A. R., Khwaja, K. O., et al. (2013) · American Journal of Nephrology · doi:10.1159/000355620 · Cited by 6
Transplant-Associated Hyperglycemia: Shedding Light on the Mechanisms
Reese, P. P., & Bloom, R. D. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01430210 · Cited by 6
Steroid avoidance or withdrawal for kidney transplant recipients
Oliveras, L., Melilli, E., Cruzado, J. M., Nagler, E. V., Webster, A. C., Pascual, J., Montero, N., & Transplant, S. B. C. K. A. (2026) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005632.pub4 · Cited by 5
Pierce, D. R., Gruessner, A. C., Campara, M., Cocco, P. D., Spaggiari, M., Tzvetanov, I. G., Tang, I. Y.-S., Benedetti, E., & Lichvar, A. B. (2023) · Clinical Transplantation · doi:10.1111/ctr.15063 · Cited by 5
Shim, Y. E., Ko, Y., Lee, J. P., Jeon, J. S., Jun, H., Yang, J., Lim, S. J., Lim, S. J., Kwon, H. E., Jung, J. H., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-39353-6 · Cited by 5
Future Trends in Organ Transplant Recipients – Important Issues for Dermatologists
Zecher, D., & Steiger, J. U. (2012) · Current problems in dermatology · doi:10.1159/000335153 · Cited by 5
Wasilewski, G., Przybyłowski, P., Janik, Ł., Nowak, E., Sadowski, J., & Małyszko, J. (2014) · Transplantation Proceedings · doi:10.1016/j.transproceed.2014.09.034 · Cited by 5
Steroid withdrawal in kidney allograft recipients
Adesina, S., Alkhudhayri, A., Patel, J. K., Naufal, M., Geara, A. S., & Azzi, J. R. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.946406 · Cited by 5
Steroid-free chronic immunosuppression in renal transplantation
Steiner, R. W. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328359226c · Cited by 5
T-Cell–Depleting Agents in Kidney Transplantation: Is There a Place for Alemtuzumab?
Gallon, L. G., Chhabra, D., & Skaro, A. I. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.09.005 · Cited by 5
Transplantation-steroid-impaired glucose metabolism: a hope for improvement?
Sever, M. Ş. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft478 · Cited by 5
Successful steroid withdrawal guided by surveillance biopsies—A single‐center experience
Wehmeier, C., Hirt‐Minkowski, P., Amico, P., Georgalis, A., Hopfer, H., Steiger, J. U., Dickenmann, M., & Schaub, S. (2017) · Clinical Transplantation · doi:10.1111/ctr.13181 · Cited by 5
Metadata
- Authors
- Woodle, E. S., First, M. R., Pirsch, J., Shihab, F., Gaber, A. O., & Van Veldhuisen, P.
- Affiliations
- University of Cincinnati (US)
- Astellas Pharma (United States) (US)
- University of Wisconsin–Madison (US)
- University of Utah (US)
- Houston Methodist (US)
- Corresponding author
- Woodle, E Steve
- Venue
- Annals of Surgery
- Published
- 2008-10
- Volume
- 248
- Issue
- 4
- Pages
- 564-577
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2026860062
- Cited by
- 474
- References
- 29
- Citations by year
- 2026: 6 · 2025: 20 · 2024: 8 · 2023: 13 · 2022: 14 · 2021: 25 · 2020: 24 · 2019: 26 · 2018: 22 · 2017: 25 · 2016: 32 · 2015: 26 · 2014: 45 · 2013: 29 · 2012: 43
- FWCI
- 29.87
- Type
- journal article
- Language
- en
- Open access
- green
- works.bepress.com
- Licence
- cc-by
- Locations
- Annals of Surgery (publishedVersion)
- PubMed (publishedVersion)
- Journal of Bioresource Management (submittedVersion)
- Journal of Bioresource Management (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
- Keywords
- corticosteroid withdrawal, kidney transplantation, prednisone, acute rejection, graft loss, patient death, antibody-mediated rejection, renal function, immunosuppression, delayed graft function, deceased donor, living donor, long-term outcomes, corticosteroid-sparing immunosuppression
- MeSH terms
- Adolescent, Adult, Aged, Biopsy, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Follow-Up Studies, Glucocorticoids, Graft Rejection, Humans, Kidney Failure, Chronic, Male, Middle Aged, Prednisone, Prospective Studies, Time Factors, Kidney Transplantation, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.